NICHOLE LEE: Open Payments
NPI 1609419639 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,244 in 22 payments from 15 companies in 2025. Trend: 2023 $2,302 · 2024 $4,237 · 2025 $1,244
Food & beverage: $771Consulting: $300Education: $173
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $300 |
| AstraZeneca Pharmaceuticals LP | 4 | $184 |
| Janssen Biotech, Inc. | 2 | $163 |
| PFIZER INC. | 1 | $117 |
| ABBVIE INC. | 1 | $95 |
| SOBI, INC | 3 | $86 |
| Aveo Pharmaceuticals, Inc. | 1 | $78 |
| Adaptive Biotechnologies Corporation | 1 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Genmab U.S., Inc. | 1 | $32 |
Products named: OJJAARA, TECVAYLI, LYNPARZA, LORBRENA, VENCLEXTA, FOTIVDA, Doptelet, clonoSEQ.
Industry payments across AZ — which companies pay providers there.
